Veradermics Incorporated (MANE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -50,734 | -27,232 | -69,995 | -28,045 | -12,400 |
| Accounts receivable | -2,780 | -1,499 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,794 | -1,055 | N/A | -1,714 | -686 |
| Other Working Capital | 5,057 | 251 | -4,533 | -1,844 | -1,476 |
| Other Operating Activity | 9,005 | 8,367 | 2,926 | 2,643 | 1,245 |
| Operating Cash Flow | $-35,658 | $-21,168 | $-71,602 | $-28,960 | $-13,317 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -428,565 | -122,988 | N/A | -24,061 | -15,731 |
| PPE Investments | -21 | N/A | -24 | -19 | -19 |
| Sale Of Investment | 50,000 | 21,689 | N/A | N/A | N/A |
| Other Investing Activity | 0 | 0 | -118,834 | 0 | 0 |
| Investing Cash Flow | $-378,586 | $-101,299 | $-118,858 | $-24,080 | $-15,750 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 711,811 | 269,113 | N/A | 129 | N/A |
| Other Financing Activity | 0 | 0 | 159,142 | 8,423 | 8,423 |
| Financing Cash Flow | $711,811 | $269,113 | $159,142 | $8,552 | $8,423 |
| Beginning Cash Position | 21,766 | 21,766 | 53,084 | 53,084 | 53,084 |
| End Cash Position | 319,333 | 168,412 | 21,766 | 8,596 | 32,440 |
| Net Cash Flow | $297,567 | $146,646 | $-31,318 | $-44,488 | $-20,644 |
| Free Cash Flow | |||||
| Operating Cash Flow | -35,658 | -21,168 | -71,602 | -28,960 | -13,317 |
| Capital Expenditure | -21 | N/A | N/A | -19 | -19 |
| Free Cash Flow | -35,679 | -21,168 | -71,602 | -28,979 | -13,336 |